ZERAFLOW BLOG
Education, evidence, and updates
Clinical research, patient education, and company news from the Zera Medical team. New posts published as milestones are reached and the science evolves.
A Growing Number of Patients Are Showing Up to Colonoscopy Already Behind
GLP-1 medications like Ozempic and semaglutide are now used by roughly 1 in 8 US adults, concentrated in the exact 50 to 64 age range colorectal cancer screening targets. New research shows GLP-1 users face more than double the odds of inadequate bowel preparation, and clinical guidance on how to manage it is still catching up. This post breaks down the scale of GLP-1 adoption, what the data shows about its effect on prep quality, and how Zera Medical is rethinking the prep process for patients the standard approach has never served well.
Why Tom Hanks, Steve Martin, and Martin Short Turned Colonoscopy Prep Into a Party
Every couple of years, three of Hollywood's most recognizable comedians turn the night before their colonoscopies into a competition, complete with card games and clear gelatin. It's a funny story, but it points to something serious: bowel prep is still the single biggest reason people delay screening. This post traces the tradition from late-night television to two separate 2024 TV nods, breaks down why the dread is so universal, and looks at how ZeraFlow is designed to move prep out of the home for good.